Seniors Fair at the Aboriginal Mother Centre, Vancouver – Nov. 7, 2019

On Thursday, Nov. 7, 2019 HepCBC had an info booth at the Seniors' 55+ Resource Fair and luncheon at the Aboriginal Mother Centre Society at 2019 Dundas Street, Vancouver. Fifty or more women and children, even a couple gentlemen, enjoyed a lovely meal, great company, interesting info booths, "endless" door prizes, and a very riveting performance by "Butterflies in Spirit". This is a local group of Aboriginal women dancers and drummers who each are dancing

The Week in Review: Oct 26 – Nov 2, 2018

Friday, Nov 2, 2018 News Recap: Report on the Pacific AIDS Network (PAN) 2018 Fall Conference in Kelowna The Pacific AIDS Network held its annual Fall Conference and AGM October 30-31 in Kelowna. HepCBC attended this year for the first time as a Full Member, due to changes in the PAN Constitution and Bylaws. New Bylaws included: PAN no longer requires its hepatitis C organizational members to offer HIV-related services. Aging and Viral Hepatitis ...

Aging and Viral Hepatitis B and C: A New Study

This comprehensive article which came out October 31, 2018, describes the challenges and impacts of hepatitis B and C on the aging population in Britain. It seems applicable to Canada as well. While we couldn’t access the longer version of the article, takeaways from the abstract included: Both hepatitis B and hepatitis C are spread through blood, are viruses, and can cause acute hepatitis (short-lasting but serious liver infection/inflammation). Bot

The Week in Review: December 15 – December 22, 2017

Friday, December 22, 2017 News Recap: Eight Genotypes: Did you know that there are now 8 genotypes and 84 subtypes of HCV that have been identified?  On the one hand this is terrible news; but on the other, a study presented at AASLD 2017 found that Vosevi was effective against them all.  Eight Genotypes and 84 Subtypes of HCV. Telemedicine: Did you know that Project ECHO (Extension for Community Health Outcomes), a fast-growing international tele...

The Hidden Disease of the Middle-Aged

Liver disease is on the rise among middle-aged Americans, but many don’t know they have it—or that they could develop it. The liver performs critical jobs, including cleaning toxins from the blood, storing energy and nutrients, digesting fats and processing medications, alcohol and food. But a host of ills and abuses can wreak havoc on the liver, from heavy drinking and infection with hepatitis B or C to a scourge known as fatty-liver disease linked to di

The Week in Review: September 22 – September 29, 2017

Friday, September 29, 2017 News Recap: Merck discontinues HCV programs. There were rumours, but now it’s official: Merck has announced that it will discontinue the development of the investigational combination regimens MK-3682B (grazoprevir/ruzasvir/uprifosbuvir) and MK-3682C (ruzasvir/uprifosbuvir) for the treatment of chronic hepatitis C virus (HCV) infection. In a statement the company said the decision was made based on a review of available Pha...

The Week in Review: August 11 – August 18, 2017

Friday, August 18, 2017 Canada Great news in Canada. Two new drug regimens have been approved:  Vosevi from Gilead is a pangenotypic for retreatment of those who have failed previous DAA therapy Gilead Receives Approval in Canada for VOSEVI™ (Sofosbuvir/Velpatasvir/Voxilaprevir) for Re-treatment of Certain Patients with Chronic Hepatitis C Virus (HCV) Infection. And MAVIRET from AbbVie is the first and only 8-week, pan-genotypic treatment for hepatit...

Direct-acting Antivirals Effective in Older Patients with Hepatitis C

Treatment of hepatitis C virus (HCV) with sofosbuvir-based direct acting antivirals (DAAs) was recently found as effective and well-tolerated in elderly patients as it was in younger patients in previous development trials. "Historically, older patients have been underrepresented in studies evaluating the efficacy and safety of HCV treatment due to poor tolerability and suboptimal response to interferon-based regimens," the researchers wrote. Satapathy

Pamphlets & Posters

Our pamphlets and posters about hepatitis B and C are aimed at various communities: General population and baby boomers Newcomer/immigrant communities (translations available) Aboriginal/northern/remote communities Prison and former prisoner communities IVDU and MSM communities All of the publications on this page can be downloaded (PDFs).  Click on the Thumbnails below to access the printable, high-resolution versions. All posters are